This webinar will discuss the evolving regulatory requirments for testing Biologics injectibles for sub-visible Particulates.
Why Should You Attend:
There is an increased scrutiny on the testing and reporting of particulates in Protein Therapeutics.
Proteinaceous Particulates in Biologics injectibles can arise from the aggregation of the protein product and can be induced by silicone droplets, metal particles and glass particles.
Who Will Benefit:
R&D Laboratory personnel
R&D Laboratory Supervisors and Management
QC Laboratory personnel and management
Protein Formulation Group personnel and Management
Regulatory Affairs personnel
Dr. Subbarao, holds a Ph.D. in Bio-organic Chemistry. She is currently a Senior Consultant with the Biologics Consulting Group specializing in Analytical, Stability, CMC and GLP/GMP Quality Systems. Her hands-on industrial experience covers stability and laboratory cGMP systems for both biologics and conventional drugs.
Use coupon code NB5SQH8N and get 10% off on registration.